HomeAI · summaries
Storia in 2 fonti
Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment
Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million…
Globally Recognized Impact Investors Back Leyden Labs’ Mission to Transform Protection Against Respiratory Viruses with €40 Million Investment
- ·
techfundingnews.com
Gates Foundation backs Leyden Labs' €40M raise: Can a nasal spray do what 80 years of flu vaccines couldn't — TFN
Dutch biotech Leyden Labs has raised €40M from EIC Fund, Invest-NL, Gates Foundation, and ClavystBio to develop nasal spray-based protection against respiratory viruses.